Ming Bioventures
Overview
Ming Bioventures is a venture capital firm founded in 2018. Based in Suzhou, China, the firm focuses on early-stage investments in the life science sectors, including innovative drugs, medical devices, emerging biotechnology, and medical diagnostics.
Portfolio Companies
7
Website
mingbioventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Abogen Biosciences | Apr 2021 | Series B | Co-investor |
| Beyond Pharmaceutical Co., Ltd. | Jul 2023 | VC Round | Lead |
| Elpiscience Biopharmaceuticals | Dec 2019 | Series B | Co-investor |
| Tyligand Bioscience | Nov 2022 | Series A Extension | Lead |
| Help Therapeutics | Nov 2021 | Series C | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ming Bioventures based?
Ming Bioventures is headquartered in Jiangsu.
When was Ming Bioventures founded?
Founding year information for Ming Bioventures is not publicly available.
How many portfolio companies does Ming Bioventures have?
Ming Bioventures has 7 portfolio companies in Caplight's dataset.
What are some companies in Ming Bioventures's portfolio?
Portfolio companies visible on Caplight include Abogen Biosciences, Beyond Pharmaceutical Co., Ltd., Elpiscience Biopharmaceuticals, Tyligand Bioscience, Help Therapeutics.
What was Ming Bioventures's most recent investment shown here?
Ming Bioventures's most recent investment in this portfolio sample was in Beyond Pharmaceutical Co., Ltd. in 2023.
What sectors does Ming Bioventures focus on?
Ming Bioventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Ming Bioventures focus on?
Ming Bioventures typically invests at the Mid stage.
What is Ming Bioventures's AUM?
Ming Bioventures's assets under management are estimated between $71.5M and $71.5M.